Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias

M. J. Carnicer, Sergio Bernardini, Lorenza Bellincampi, N. I. Noguera, Marzia Nuccetelli, Emanuele Ammatuna, Massimo Breccia, Francesco Lo-Coco, Giorgio Federici

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Elevated levels of glutathione (GSH) have been reported to play an important role in mediating chemoresistance in tumor cells. The regulation of γ-glutamylcysteine synthetase (γ-GCS) is one of the major determinants of GSH homeostasis. The aim of our study was to investigate γ-GCS gene expression in patients affected by acute myeloid leukemia (AML). Methods: A total of 64 AML samples, including 23 acute promyelocytic leukemia (APL or M3) cases, were included in the study. γ-GCS mRNA levels were determined by real-time quantitative RT-PCR. All patients were evaluated at diagnosis, whereas post-treatment γ-GCS mRNA levels were assessed at the end of the consolidation therapy in 16 cases. Results: Our data showed that variable degrees of γ-GCS expression were detectable in AML, likely reflecting disease heterogeneity; in particular, APL cases, compared to the other AML subsets, showed both significantly lower basal levels of γ-GCS mRNA at presentation and significantly increased mRNA levels after treatment. Conclusions: Decreased levels of γ-GCS leading to reduced GSH may at least in part explain the higher sensitivity of APL to chemotherapy.

Original languageEnglish
Pages (from-to)342-345
Number of pages4
JournalClinica Chimica Acta
Volume365
Issue number1-2
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Ligases
Acute Myeloid Leukemia
Gene expression
Cysteine
Gene Expression
Messenger RNA
Pharmaceutical Preparations
Glutamate-Cysteine Ligase
Acute Promyelocytic Leukemia
Chemotherapy
Consolidation
Glutathione
Tumors
Real-Time Polymerase Chain Reaction
Homeostasis
Therapeutics
Cells
Drug Therapy
Neoplasms

Keywords

  • γ-glutamyl cysteine synthetase
  • Acute myeloid leukemia
  • Acute promyelocytic leukemia
  • Glutathione transferase P1-1

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias. / Carnicer, M. J.; Bernardini, Sergio; Bellincampi, Lorenza; Noguera, N. I.; Nuccetelli, Marzia; Ammatuna, Emanuele; Breccia, Massimo; Lo-Coco, Francesco; Federici, Giorgio.

In: Clinica Chimica Acta, Vol. 365, No. 1-2, 03.2006, p. 342-345.

Research output: Contribution to journalArticle

Carnicer, MJ, Bernardini, S, Bellincampi, L, Noguera, NI, Nuccetelli, M, Ammatuna, E, Breccia, M, Lo-Coco, F & Federici, G 2006, 'Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias', Clinica Chimica Acta, vol. 365, no. 1-2, pp. 342-345. https://doi.org/10.1016/j.cca.2005.09.012
Carnicer, M. J. ; Bernardini, Sergio ; Bellincampi, Lorenza ; Noguera, N. I. ; Nuccetelli, Marzia ; Ammatuna, Emanuele ; Breccia, Massimo ; Lo-Coco, Francesco ; Federici, Giorgio. / Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias. In: Clinica Chimica Acta. 2006 ; Vol. 365, No. 1-2. pp. 342-345.
@article{21183361fd404a358c113df625391743,
title = "Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias",
abstract = "Background: Elevated levels of glutathione (GSH) have been reported to play an important role in mediating chemoresistance in tumor cells. The regulation of γ-glutamylcysteine synthetase (γ-GCS) is one of the major determinants of GSH homeostasis. The aim of our study was to investigate γ-GCS gene expression in patients affected by acute myeloid leukemia (AML). Methods: A total of 64 AML samples, including 23 acute promyelocytic leukemia (APL or M3) cases, were included in the study. γ-GCS mRNA levels were determined by real-time quantitative RT-PCR. All patients were evaluated at diagnosis, whereas post-treatment γ-GCS mRNA levels were assessed at the end of the consolidation therapy in 16 cases. Results: Our data showed that variable degrees of γ-GCS expression were detectable in AML, likely reflecting disease heterogeneity; in particular, APL cases, compared to the other AML subsets, showed both significantly lower basal levels of γ-GCS mRNA at presentation and significantly increased mRNA levels after treatment. Conclusions: Decreased levels of γ-GCS leading to reduced GSH may at least in part explain the higher sensitivity of APL to chemotherapy.",
keywords = "γ-glutamyl cysteine synthetase, Acute myeloid leukemia, Acute promyelocytic leukemia, Glutathione transferase P1-1",
author = "Carnicer, {M. J.} and Sergio Bernardini and Lorenza Bellincampi and Noguera, {N. I.} and Marzia Nuccetelli and Emanuele Ammatuna and Massimo Breccia and Francesco Lo-Coco and Giorgio Federici",
year = "2006",
month = "3",
doi = "10.1016/j.cca.2005.09.012",
language = "English",
volume = "365",
pages = "342--345",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias

AU - Carnicer, M. J.

AU - Bernardini, Sergio

AU - Bellincampi, Lorenza

AU - Noguera, N. I.

AU - Nuccetelli, Marzia

AU - Ammatuna, Emanuele

AU - Breccia, Massimo

AU - Lo-Coco, Francesco

AU - Federici, Giorgio

PY - 2006/3

Y1 - 2006/3

N2 - Background: Elevated levels of glutathione (GSH) have been reported to play an important role in mediating chemoresistance in tumor cells. The regulation of γ-glutamylcysteine synthetase (γ-GCS) is one of the major determinants of GSH homeostasis. The aim of our study was to investigate γ-GCS gene expression in patients affected by acute myeloid leukemia (AML). Methods: A total of 64 AML samples, including 23 acute promyelocytic leukemia (APL or M3) cases, were included in the study. γ-GCS mRNA levels were determined by real-time quantitative RT-PCR. All patients were evaluated at diagnosis, whereas post-treatment γ-GCS mRNA levels were assessed at the end of the consolidation therapy in 16 cases. Results: Our data showed that variable degrees of γ-GCS expression were detectable in AML, likely reflecting disease heterogeneity; in particular, APL cases, compared to the other AML subsets, showed both significantly lower basal levels of γ-GCS mRNA at presentation and significantly increased mRNA levels after treatment. Conclusions: Decreased levels of γ-GCS leading to reduced GSH may at least in part explain the higher sensitivity of APL to chemotherapy.

AB - Background: Elevated levels of glutathione (GSH) have been reported to play an important role in mediating chemoresistance in tumor cells. The regulation of γ-glutamylcysteine synthetase (γ-GCS) is one of the major determinants of GSH homeostasis. The aim of our study was to investigate γ-GCS gene expression in patients affected by acute myeloid leukemia (AML). Methods: A total of 64 AML samples, including 23 acute promyelocytic leukemia (APL or M3) cases, were included in the study. γ-GCS mRNA levels were determined by real-time quantitative RT-PCR. All patients were evaluated at diagnosis, whereas post-treatment γ-GCS mRNA levels were assessed at the end of the consolidation therapy in 16 cases. Results: Our data showed that variable degrees of γ-GCS expression were detectable in AML, likely reflecting disease heterogeneity; in particular, APL cases, compared to the other AML subsets, showed both significantly lower basal levels of γ-GCS mRNA at presentation and significantly increased mRNA levels after treatment. Conclusions: Decreased levels of γ-GCS leading to reduced GSH may at least in part explain the higher sensitivity of APL to chemotherapy.

KW - γ-glutamyl cysteine synthetase

KW - Acute myeloid leukemia

KW - Acute promyelocytic leukemia

KW - Glutathione transferase P1-1

UR - http://www.scopus.com/inward/record.url?scp=32044437367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044437367&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2005.09.012

DO - 10.1016/j.cca.2005.09.012

M3 - Article

VL - 365

SP - 342

EP - 345

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -